Drugs / SCH 900800
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01500707 | Jan → Jul 2013 | Parkinson disease | Merck Sharp & Dohme LLC | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCH 900800 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01500707 ↗ |
| Route | Oral | “SCH 900800, one 20 mg tablet, orally” NCT01500707 ↗ |